BioPharma Dive ٢٤ نوفمبر ٢٠٢٥ FDA probes effects of Takeda rare disease drug after patient death #FDA probes #Takeda rare
Endpoints News ٢١ نوفمبر ٢٠٢٥ AstraZeneca to onshore rare disease portfolio as part of its $50B pledge to the US #announced Friday #billion pledge
Illumina ٢٩ مايو ٢٠٢٥ Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis - Illumina #unveils PromoterAI #Illumina unveils